M&A Deal Summary

Capsugel Belgium NV Acquires PowderSize

On December 14, 2015, Capsugel Belgium NV acquired life science company PowderSize

Acquisition Highlights
  • This is Capsugel Belgium NV’s 5th transaction in the Life Science sector.
  • This is Capsugel Belgium NV’s 3rd transaction in the United States.
  • This is Capsugel Belgium NV’s 1st transaction in Pennsylvania.

M&A Deal Summary

Date 2015-12-14
Target PowderSize
Sector Life Science
Buyer(s) Capsugel Belgium NV
Deal Type Add-on Acquisition

Target

PowderSize

Quakertown, Pennsylvania, United States
Powdersize is a customer service-driven contract manufacturer, providing expertise in particle-size reduction and particle-size control technologies intended for powders used within the pharmaceutical, medical and food marketplaces. With two decades of manufacturing experience, Powdersize can develop a robust process at any scale of development, including R&D, pilot scale or commercial scale. The company combines extensive experience and its unique ability to design custom jet milling systems appropriate for the client’s need. The company is one of the leading contract manufacturers offering milling and micronization services in the United States.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Capsugel Belgium NV

Colmar, France

Category Company
Founded 1875
Sector Life Science
Revenue 750M USD (2010)
DESCRIPTION

Capsugel Belgium NV is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Capsugel offers a comprehensive array of products and services, from hard gelatin, vegetarian and liquid-filled capsules, to innovative R&D equipment and liquid formulations as part of its Licaps Drug Delivery System.


DEAL STATS #
Overall 5 of 5
Sector: Life Science M&A 5 of 5
Type: Add-on Acquisition M&A Deals 4 of 4
State: Pennsylvania M&A 1 of 1
Country: United States M&A 3 of 3
Year: 2015 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-14 Xcelience

Tampa, Florida, United States

Xcelience offers a suite of services enabling clients to partner with a single CDMO for all of their global clinical outsourcing needs. Services include preformulation, micronization, analytical services, formulation development, cGMP manufacturing, small-scale commercial manufacturing, and global clinical supplies packaging and logistics. Xcelience takes pride in delivering the highest standards in science and service with an emphasis on quality, cost and speed.

Buy -